The Flair trial found that 94 per cent of patients who received the two targeted drugs were alive with no disease progression ...

The findings of the UK-wide study, led by researchers from Leeds, could reshape the way the most common form of leukaemia in ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

The Flair trial saw two targeted cancer drugs perform better than standard chemotherapy, halting disease progression in 94% ...

Personalised drug treatments have outperformed chemotherapy for leukaemia patients in a trial led by Leeds researchers.